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Background: Klinefelter syndrome (KS), caused by XXY karyotype, is characterized by low testosterone, infertility,
cognitive deficits, and increased prevalence of health problems including obesity and diabetes. It has been difficult
to separate direct genetic effects from hormonal effects in human studies or in mouse models of KS because low
testosterone levels are confounded with sex chromosome complement.
Methods: In this study, we present the Sex Chromosome Trisomy (SCT) mouse model that produces XXY, XYY, XY,
and XX mice in the same litters, each genotype with either testes or ovaries. The independence of sex
chromosome complement and gonadal type allows for improved recognition of sex chromosome effects that are
not dependent on levels of gonadal hormones. All mice were gonadectomized and treated with testosterone for 3
weeks. Body weight, body composition, and motor function were measured.
Results: Before hormonal manipulation, XXY mice of both sexes had significantly greater body weight and relative
fat mass compared to XY mice. After gonadectomy and testosterone replacement, XXY mice (both sexes) still had
significantly greater body weight and relative fat mass, but less relative lean mass compared to XY mice. Liver,
gonadal fat pad, and inguinal fat pad weights were also higher in XXY mice, independent of gonadal sex. In several
of these measures, XX mice also differed from XY mice, and gonadal males and females differed significantly on
almost every metabolic measure. The sex chromosome effects (except for testis size) were also seen in gonadally
female mice before and after ovariectomy and testosterone treatment, indicating that they do not reflect group
differences in levels of testicular secretions. XYY mice were similar to XY mice on body weight and metabolic
variables but performed worse on motor tasks compared to other groups.
Conclusions: We find that the new SCT mouse model for XXY and XYY recapitulates features found in humans
with these aneuploidies. We illustrate that this model has significant promise for unveiling the role of genetic
effects compared to hormonal effects in these syndromes, because many phenotypes are different in XXY vs. XY
gonadal female mice which have never been exposed to testicular secretions.
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Klinefelter syndrome (KS), caused by the karyotype
XXY, is characterized by small testes, azoospermia, low
testosterone, hypergonadotropism, and gynecomastia
[1,2]. The prevalence of the KS karyotype is 1 in 600 live
male births, making it the most common genetic cause
of male infertility [3-6]. In addition to the gonadal phe-
notypes, KS men have non-gonadal traits and symptoms.
For example, KS men are taller than XY siblings or peers
and exhibit specific cognitive deficits—especially involv-
ing language, social, and executive functioning skills
[7-16]. Another sex chromosome trisomy, XYY, does not
cause infertility or hypogonadism, but XYY boys exhibit
similar cognitive deficits to those seen in KS [9,15].
KS men also experience an increased prevalence of sev-
eral health problems [17,18], some of which are usually
more common in women than in men including breast
cancer [19,20], osteoporosis [21,22], and autoimmune dis-
eases such as rheumatoid arthritis and systemic lupus
erythematosus [23-26]. Relative to XY males, KS men have
increased body fat, specifically abdominal fat, as well as in-
creased rates of hyperinsulinemia, insulin resistance, type II
diabetes, and metabolic syndrome [27-33]. It is generally
believed that hypogonadism is primarily responsible for the
metabolic phenotype seen in KS patients. Treatment with
testosterone can provide improved outcomes for some KS
phenotypes [34,35] but is not sufficient to improve
metabolic features [28]. Moreover, KS boys suffer from
metabolic syndrome before puberty, when testosterone
levels are similarly low in both KS boys and controls [31].
Additionally, a recent study comparing men with KS vs.
men with idiopathic hypogonadotrophic hypogonadism
(IHH) showed that men with KS had greater rates of
diabetes than men with IHH both before and after both
groups received testosterone replacement therapy [33].
Taken together, these results suggest that there are likely to
be direct genetic effects of the second X chromosome on
metabolism, not exclusively mediated by reduced androgen
levels in KS males.
Boys and men with KS also have impaired motor
cognition and function. Several studies suggest that KS
boys are clumsy and do not like sports [14]. KS boys
show impairments in gross motor function [36-38], fine
motor function [14,36,39], sensorimotor integration
[37,38], and overall strength and speed [38]. These defi-
cits begin early in life [37] and persist into adulthood
[40,41]. Although XYY males are studied less often, they
also show motor deficits similar to those seen in KS
including fine motor impairment, gross motor impair-
ment, decreased sensorimotor integration, and deficits
in coordination [37,38].
KS males may experience lower levels of testicular an-
drogens at various life stages. These hormones are
known to act pre- and post-natally to cause permanent(‘organizational’) effects on various tissues. They also act
more acutely and reversibly at all life stages (‘activational’
effects) [42]. Although it is impossible to cleanly separate
direct genetic effects from those caused by lower hormone
levels in humans, here, we offer a new mouse model of
XXY and XYY with improved discrimination of hormonal
vs. chromosomal effects, as well as their interactions.
The Sex Chromosome Trisomy (SCT) model produces
XXY, XYY, XY, and XX mice, each genotype with either
testes or ovaries, all within the same litters. The model
allows comparison of four different sex chromosome
genotypes and models both XXY and XYY human triso-
mies. The effects of sex chromosome complement are
tested after exposure to ovarian or testicular secretions
and after removal of these hormones by adult gonadec-
tomy, which allows for assessment of the hormonal
independence of sex chromosome effects as well as as-
sessment of interactions of sex chromosomes and hor-
mones. To validate the SCT model, we measured body
composition and motor function, which are each known




The Sex Chromosome Trisomy model (designed by P
Burgoyne, personal communication; similar to mice used
by Park et al. [43]) involves mating XXY− females with
the XY−(Sry+) males (Figure 1A). The Y− (‘Y minus’)
chromosome is deleted for the testis-determining gene
Sry so that the Y chromosome no longer causes differen-
tiation of testes [44]. The XY−(Sry+) fathers possess an
Sry transgene inserted into an autosome, which comple-
ments the lack of Sry on the Y chromosome and pro-
duces a fully functional male [45-47]. The mothers
produce X and XY− eggs, and the fathers produce X or
Y− sperm each with or without Sry. A total of eight
genotypes are produced: gonadal males XXY−(Sry+),
XY−Y−(Sry+), XY−(Sry+), and XX(Sry+), as well as go-
nadal females XXY−, XY−Y−, XY−, and XX (Figure 1A).
Here, we refer to these genotypes respectively as XXYM,
XYYM, XYM, XXM, XXYF, XYYF, XYF, and XXF. For
this study, the XXY− mothers were produced by crossing
XX females to XY−Y*X(Sry+) males, which are made by
crossing XY*X females to XY−(Sry+) males (see [48-51]
for discussion of the Y*X chromosome). More recently,
we produce XXY− mothers by breeding XY− females to
wild-type XY males, a more straightforward breeding
scheme in which about 30% of female offspring are
XXY−. To our knowledge, the SCT model is easier to
produce using outbred rather than inbred strains. Group
sizes were 11 XXYF, 9 XXYM, 8 XYYF, 8 XYYM, 21
XYF, 14 XYM, 14 XXF, and 9 XXM. Measurements of
brain gene expression and partner preference behavior
Figure 1 Cross producing the eight genotypes of the SCT model (A) and project timeline (B). All mice were outbred MF1 strain. We
attempt to maintain genetic diversity in our colony, but the X chromosomes of all mice used here were identical and derived originally from
mating an XY mouse with his XO dam to produce a line of mice with identical X chromosomes bred onto outbred stock (P Burgoyne, personal
communication). Thus, in these experiments, differences between mice with one vs. two X chromosomes were attributable to the number of X
chromosomes, not to a difference in X alleles.
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work).
All experiments were approved by the UCLA Animal
Research Committee. Mice were group-housed based on
their gonadal sex and maintained at 23°C on a 12:12
light/dark cycle. Mice were fed regular chow diet with
5% fat (LabDiet 5001, St. Louis, MO, USA).
Gonadectomy and hormonal implants
The SCT model primarily models XXY and XYY male
genotypes of humans, which are normally only present
in individuals with testes. Accordingly, the effects of
these genotypes, relative to normal XY genotype, might
be detected only when testosterone is present. There-
fore, in the current study, all mice were gonadectomized
during adulthood at 97–124 days of age and implanted
with a testosterone pellet at the time of gonadectomy
(Figure 1B). The intent was to make circulating gonadal
hormone levels as similar as possible so that group
differences could not be attributed to different levels
of gonadal hormones in adulthood. Testosterone pellets
contained 5 mm of testosterone (Steraloids, Inc.,
Newport, RI, USA) packed into a Silastic tube (1.57 mm
ID × 2.41 mm OD, Dow Corning, Midland, MI, USA)
and sealed at each end with 3 mm of medical grade
Silastic adhesive (Dow Corning). Age of the mice at thetime of gonadectomy did not differ across groups (over-
all ANOVA, p > 0.05).
Genotyping
Karyotypes were determined from metaphase spreads
prepared from tail or ear fibroblasts, using routine
methods [52].
Measurement of plasma levels of testosterone
Plasma was collected from the carotid artery following
decapitation and then stored at −20°C until radio-
immunoassay was performed by the Ligand Assay
and Analysis Core at the University of Virginia Center
for Research in Reproduction (supported by NICHD
(SCCPIR) grant U54-HD28934). Measurements were
performed in singlet reactions using Siemens Medical
Solutions Diagnostics' testosterone RIA (Malvern, PA,
USA) with a reportable range of 0.72–111.00 ng/L.
Body weight, body composition, and metabolic measures
Body weight and composition were measured just prior
to gonadectomy and at the end of the experiment (see
Figure 1B). A nuclear magnetic resonance (NMR) Mouse
Minispec apparatus (Bruker Woodlands, TX, USA) with
Echo Medical Systems (Houston, TX, USA) software was
used to measure fat and lean mass [53] with coefficients
Chen et al. Biology of Sex Differences 2013, 4:15 Page 4 of 13
http://www.bsd-journal.com/content/4/1/15of variation of less than 3%. Correlation between NMR
and gravimetric measurements is better than 0.99. NMR
was performed the day before gonadectomy (GDX) and
3 weeks after GDX.
At the end of the experiment (Figure 1B), the weights
of two specific fat pads were measured, visceral fat of
the peri-gonadal depot (referred to here as gonadal fat)
and the subcutaneous fat depot from the femoral region
(referred to as inguinal fat). Both depots were assessed
because visceral and subcutaneous fat depots are
differentially regulated and have diverse positive and
negative effects on metabolic syndrome in humans and
mice [54,55].Testis size
At the time of gonadectomy, testes were classified as
small, medium, or normal (large) by a researcher who
was blind to the genotype. All XYM had normal testes,
all XYYM had medium testes, and all XXM and XXYM
had small testes, except for one XXYM that had medium
testes.Motor tests 3 weeks after GDX
At 18–22 days after GDX, motor function was assessed
using two sensitive tests, the challenging beam traversal
test and the pole test [56,57]. The challenging beam test
required mice to traverse a 1-m-long beam made up of
four 25-cm-long sections of decreasing width (3.5 cm at
its widest and 0.5 cm at its narrowest, decreasing by 1-
cm increments). Mice were trained to traverse the beam
starting at the widest section and ending at their home
cage, which was placed at the end of the narrowest sec-
tion. Mice received two consecutive days of training,
making five traversals each day, and were tested on the
third day. On the testing day, the beam traversal was
made more challenging by adding a wire grid to the top
of the beam so that mice had to grasp the wire to
complete traversal, and errors could be calculated based
on misses or slips while grasping. During testing, mice
were video recorded making five traversals of the beam.
The following variables were scored from videos of the
behavior: time to traverse the beam, number of steps,
and number of errors.
The pole test involved placing the mouse head up at
the top of a 50-cm-long, 1-cm-diameter vertical wooden
pole with the base of the pole in the animal's home cage.
Mice were trained to turn around, to face down, and
traverse down the pole into their home cage. Mice re-
ceived two consecutive days of training, making five tra-
versals each day. On the third day, the mice were video
recorded making five traversals. The following variables
were later scored from videos: time to turn around and
time to reach the base of the pole.Training for the challenging beam traversal test and
the pole test were done consecutively for each mouse,
such that each mouse completed training for the pole
before training for the beam in a single session. Testing
on the third day was done similarly, with each mouse
completing the pole test then immediately completing
the beam test.
Statistical analyses
An overall analysis of variance (ANOVA) was used to
compare the eight groups, with factors of gonadal sex
(Sry present vs. absent) and genotype (four levels). In
addition, our a priori hypotheses were that XY mice
differed pairwise with XX, XXY, and XYY, and these
comparisons were tested with three separate two-way
ANOVAs with factors of gonadal sex and genotype (two
levels). In two cases, we used body weight as a covariate
in an analysis of covariance (ANCOVA) to determine if
group differences in the dependent variable were attrib-
utable to differences in body weight.
Results
In gonadally intact mice, XXY (but not XYY) sex
chromosome complement was associated with greater
body weight and adiposity
Mice were weighed just before gonadectomy. At this
time, gonadal males were significantly heavier (25%)
than gonadal females regardless of sex chromosome
complement, and there was no overall effect of sex
chromosome complement (Figure 2A). In pairwise com-
parisons, XXY mice weighed significantly more (13%)
than XY mice regardless of gonadal type, but XY did not
differ from XX or XYY. Gonadal males also had signifi-
cantly greater relative fat mass (32%, Figure 2B), and sig-
nificantly greater (70%) absolute fat mass than gonadal
females (in Additional file 1: Figure S1A), but there was
no overall effect of sex chromosome complement on ei-
ther measure. In pairwise comparisons, XXY mice had
significantly more (24%) relative fat mass than XY mice,
but XY did not differ from XX or XYY, and there was
no effect of sex chromosome complement on absolute
fat mass. Relative lean mass was not affected by sex or
sex chromosome complement in the overall analysis
(Figure 2C), but gonadal males had significantly greater
(21%) absolute lean mass than gonadal females (in
Additional file 1: Figure S1B); there was a significant ef-
fect of sex chromosome complement on absolute lean
mass. In pairwise comparisons for relative lean mass,
there was no significant effect of sex chromosome com-
plement, but XXY mice had significantly more (10%) ab-
solute lean mass than XY (in Additional file 1: Figure
S1B), but XY did not differ from XX or XYY. Thus, the
gonadally intact XXY mice resembled KS men in having
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Figure 2 Body weight and composition just before gonadectomy. (A) Gonadal males were about 25% heavier than gonadal females
(F(1,86) = 42.09, *p < 0.000001, overall ANOVA). In pairwise tests, XY mice weighed 13% less than XXY regardless of gonadal type (F(1,51) = 6.65,
*p = 0.013). (B) Gonadal males had about 32% more body fat as percentage of body weight compared to gonadal females (F(1,86) = 6.05, *p = 0.015,
overall ANOVA). In pairwise comparisons, XY had about 24% less body fat as percentage of body weight than XXY irrespective of gonadal sex (F(1,51) =
4.74, *p = 0.034). (C) Lean mass as percentage of body weight was unaffected by sex or sex chromosome complement. F gonadal females, M gonadal
male. Values are mean ± SEM.
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These differences were independent of gonadal sex and
suggest that XXY chromosome complement influences
metabolism leading to altered body composition.
After GDX and testosterone treatment, XXY mice had
greater body weight and adiposity than XY mice
To remove confounding effects of endogenous gonadal
secretions, we performed GDX and restored testosterone
in mice of all genotypes by testosterone pellet implant-
ation. Three weeks after GDX and testosterone pellet
implantation, all mice had testosterone levels in the
physiological range (170–1,440 ng/dL). There were no
differences across genotypes, but gonadal females had
significantly higher (14%) testosterone levels than males
(Figure 3A). The sex difference in the level of testoster-
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Figure 3 Plasma testosterone and body weight and composition afte
testosterone did not differ as a function of sex chromosome complement
testosterone (F(1,84) = 4.91, p = 0.029). (B) Gonadal males were about 26%
mice weighed 13% less than XXY irrespective of gonadal sex (F(1,51) = 7.40
gonadal females (F(1,84) = 37.75, *p < 0.000001), and there was a significan
0.007). XY mice had 43% less relative fat mass than XXY mice (F(1,51) = 13.
irrespective of gonadal sex. (D) Relative lean mass was 6% lower in gonada
ANOVA). In pairwise comparisons, XY had 4% greater relative lean mass thamales, because using body weight as a covariate in an
ANCOVA eliminated the significant sex difference in
the level of testosterone. Thus, we generated mice that
do not differ in testosterone levels across genotype
within sex. We assessed body weight and composition
and related metabolic parameters in these animals.
Three weeks after GDX and testosterone pellet im-
plantation, gonadal males were still significantly heavier
(26%) than gonadal females (Figure 3B), but there was
no overall effect of sex chromosome complement. In
pairwise comparisons, XXY mice weighed 13% more
than XY, but XY did not differ from XX or XYY.
Gonadal males had significantly greater relative (69%)
and absolute (121%) fat mass than gonadal females
(Figure 2C; in Additional file 1: Figure S2A). In addition,
sex chromosome complement had a significant overall
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r gonadectomy and testosterone treatment. (A) Plasma
within sex, but gonadal females had overall 14% higher levels of
heavier than gonadal females (F(1,84) = 63.13, *p < 0.000001), and XY
, *p = 0.009). (C) Gonadal males had 69% more relative fat mass than
t overall effect of sex chromosome complement (F(3,84) = 4.30, *p =
18, *p < 0.0007), and 21% less than XX mice (F(1,53) = 4.20, *p = 0.045),
l males than in females (F(1,84) = 29.21, *p = 0.000001, overall
n XXY (F(1,51) = 6.63, *p = 0.013). Values are mean ± SEM.
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and XX had 21% more than XY mice (Figure 3C). Abso-
lute fat mass was 60% higher in XXY compared to XY
mice (in Additional file 1: Figure S2B). Fat mass was not
different in XY relative to XX or XYY. Relative lean
mass was 6% lower in gonadal males than in gonadal fe-
males (Figure 3D), but absolute lean mass was 17%
greater in gonadal males than females (in Additional file
1: Figure S2B). In pairwise comparisons, XXY had 4%
lower relative lean mass than XY, and XYY had 7% more
absolute lean mass than XY. XY did not differ from XX
or XYY in relative or absolute lean mass. Thus, the XXY
genotype (but not XYY) was associated with increased
body weight due to increases in both absolute fat and
lean mass, and these animals had a higher proportion of
their body mass as fat than XY mice.
GDX and testosterone treatment interact with sex and
genotype to change body composition
To assess group differences in the effect of gonadectomy
plus testosterone treatment, we used the change in body
weight and composition (measurements at the end of
the experiment minus measurements before GDX) as
the dependent variable. There was no significant overall
effect of sex or sex chromosome complement on the
change in body weight. In pairwise comparisons, XYY
gained more weight than XY (Figure 4A). Females had a
significantly greater loss in relative fat mass (Figure 4B)
and greater gain in relative lean mass (Figure 4C)
compared to males, but there was no overall effect of
sex chromosome complement on these measures. There
were significant interactions between sex chromosome
complement and gonadal sex in pairwise comparisons of
XY with all three other groups for body weight and
when comparing XY with XX for change in relative lean
mass (Figure 4A,C). There were no significant effects ofA Change in Body Weight B Change in r



























Figure 4 Change in body weight and composition caused by gonade
weight than XY (F(1,46) = 4.58, p = 0.038, main effect). In addition, the chan
chromosome complement when comparing XY with XX (F(1,53) = 0.020, p
Gonadal females overall lost more relative fat mass than gonadal males (F(1
chromosome complement. (C) Gonadal females overall gained more relativ
difference between XY and XX was different depending on their gonadal s
of gonadal sex and sex chromosome complement. Values are mean ± SEMsex or sex chromosome complement on the change in
absolute fat mass or lean mass (data not shown).
After GDX and testosterone treatment, XXY mice had
heavier metabolic tissues than XY mice
To further define the basis for differences in body weight
and composition among genotypes, we measured the
weights of key metabolic tissues, including representa-
tive visceral and subcutaneous fat pads (gonadal and in-
guinal fat depots, respectively), liver, spleen, and kidney.
Except for the spleen, each of these tissues was signifi-
cantly heavier in gonadal males than females (Figure 5).
There was also a significant overall effect of sex chromo-
some complement on liver weight. In pairwise compari-
sons, XXY had significantly heavier liver, gonadal fat pad
and inguinal fat pad compared to XY (Figure 5A–C),
and XY did not differ from XX or XYY. There were no
group differences in spleen weights.
Differences in body weight and composition between
XXY and XY occurred in gonadal female groups
Because XXY male mice may have lower testosterone
levels than XY males during development [58,59], differ-
ences between XXY and XY mice could be caused by
organizational effects of testicular hormones. To test
whether differences exist under conditions in which the
XXY vs. XY comparison is unlikely to be confounded by
androgen levels in this manner, we assessed sex chromo-
some effects in females only, using one-way ANOVAs
with sex chromosome complement as the factor. Before
GDX (Figure 2; in Additional file 1: Figure S1), there
was a significant effect of sex chromosome complement
in females on body weight (F(3,50) = 4.78, p = 0.005,
overall one-way ANOVA), relative fat mass (F(3,50) =
2.79, p = 0.05), absolute fat mass (F(3,50) = 3.39, p =
0.025), relative lean mass (F(3,50) = 3.73, p = 0.017), andelative fat mass C  Change in relative lean mass
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Figure 5 Tissue weights after gonadectomy and treatment with testosterone. All tissue weights except spleen were greater in gonadal
males than females in the overall ANOVA (liver, F(1,85) = 13.05, *p = 0.0005; inguinal fat, F(1,86) = 19.41, *p = 0.00003; gonadal fat, F(1,50) =
23.29, *p = 0.00001; kidney, F(1,86) = 7.28, *p = 0.008), and sex chromosome complement affected liver weight in the overall ANOVA (F(3,85) =
3.84, *p = 0.012). XXY mice had heavier livers (A), and gonadal (B) and inguinal (C) fat pads, compared to XY (liver, F(1,51) = 8.13, *p =
0.006; gonadal fat F(1,29) = 7.61, *p = 0.01; inguinal fat, F(1,51) = 4.55, *p = 0.038). There were no group differences in spleen (D)
weights. Values are mean ± SEM.
Chen et al. Biology of Sex Differences 2013, 4:15 Page 7 of 13
http://www.bsd-journal.com/content/4/1/15absolute lean mass (F(3,50) = 3.25, p = 0.029). Notably,
in pairwise comparisons, XXYF differed from XYF in
each of these measures (with greater body weight and fat
and less relative lean mass, p < 0.009, t test). XYF also
differed from XXF in each of these measures except rela-
tive fat mass (p < 0.045, t test).
After GDX and testosterone treatment (Figure 3; in
Additional file 1: Figure S2), there was a significant effect
of sex chromosome complement on body weight (F
(3,48) = 2.82, p = 0.049, overall one-way ANOVA), rela-
tive fat mass (F(3,48) = 5.27, p = 0.003), absolute fat
mass (F(3,48) = 5.66, p = 0.002), and relative lean mass
(F(3,48) = 4.42, p = 0.008). In pairwise comparisons,
XXYF differed from XYF in each of these measures
(with greater body weight and relative fat and less rela-
tive lean mass, p < 0.022, t test). XYF also differed from
XXF in each of these measures (p < 0.036, t test). In re-
sponse to GDX and testosterone treatment, there was a
significant effect of sex chromosome complement on the
change in body weight (F(3,48) = 2.81, p = 0.049, overall
one-way ANOVA) (Figure 4A), but not in other mea-
sures. In pairwise comparisons, XXYF had less change in
body weight than XYF (p = 0.026, t test), and XYF had
greater change in body weight than XXF (p = 0.044, ttest) (Figure 4A). In tissue weights (Figure 5), there was
a significant effect of sex chromosome complement for
inguinal fat pad weight (F(3,50) = 7.67, p = 0.0003, over-
all one-way ANOVA) and relative inguinal fat pad
weight (F(3,50) = 7.58, p = 0.0003), but not for other tis-
sues. In pairwise comparisons, XXYF differed from XYF
for liver weight (p = 0.012, t test), gonadal fat pad weight
(p = 0.019, t test), and inguinal fat pad weight (p <
0.000001, t test) (Figure 5). XYF also differed from XXF
for inguinal fat pad weight (p = 0.007, t test). There were
no significant differences between XYF and XYYF on
any measure. Thus, even under conditions in which
mice have never had testes, the second X chromosome
of the XXY genotype influences body composition and
metabolic tissue weights.
XYY mice differed from XY mice in tests of
motor function
In the challenging beam test, gonadal males took signifi-
cantly longer (38%) to cross the beam compared to fe-
males (Figure 6A). In pairwise comparisons, there was a
significant sex by sex chromosome complement inter-
action for XY compared to XX such that XX gonadal
males (but not gonadal females) took longer to cross the
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Figure 6 Motor performance. (A) In the challenging beam test, gonadal males took 38% longer to cross the beam compared to females
(F(1,85) = 12.45, p = 0.0007, overall ANOVA) XX gonadal males took longer to cross the beam than XY males, but XX and XY females did not
differ (F(1,53) = 4.60, p = 0.037, *INT). (B) Gonadal males took 7% more steps to cross the beam compared to gonadal females (F(1,85) = 4.41,
p = 0.04, overall ANOVA), but the effect of sex depended on the genotype (F(3,85) = 7.02, p = 0.0003, *INT). In pairwise comparisons, the
difference between XY and XX, and XY and XYY, depended on sex (F(1,53) = 5.25, p = 0.026 and F(1,46) = 4.78, p = 0.034, respectively, *INT).
(C) In time to turn on the pole, the difference between XY and XYY mice depended on their sex (F(1,46) = 6.80, p = 0.012, *INT). (D) In time to
complete the pole test, the difference between XY and XYY mice depended on their sex (F(1,46) = 4.62, p = 0.037, *INT). *INT indicates significant
interactions of gonadal sex and sex chromosome complement. Values are mean ± SEM.
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more steps to cross the beam compared to gonadal fe-
males (Figure 6B), and the effect of sex differed depend-
ing on sex chromosome complement. In pairwise
comparisons, there were sex by sex chromosome com-
plement interactions such that XX took more steps than
XY but only in gonadal males, and the XYY vs. XY dif-
ference was not consistently in the same direction for
gonadal males and females. There were no significant
sex or sex chromosome complement effects on errors in
any section of the beam (data not shown).
For the pole test, there was no overall effect of sex or
sex chromosome complement (Figure 6C,D), but in pair-
wise comparisons, there were significant sex by sex
chromosome complement interactions such that XYY
males (but not females) took longer to turn and
complete the test than XY. Because the mice differed in
body weight and because increased body weight could
make completion of the pole test more difficult, we ana-
lyzed the pole data using an ANCOVA with weight asthe covariate but found that weight does not explain any
of the group differences.
Discussion
Here we introduce a novel mouse model, the Sex
Chromosome Trisomy model, which compares XXY,
XYY, XY, and XX mice within litters. Because gonadal
sex is independent of sex chromosome complement, the
effects of sex chromosome complement can be assessed
independently of the exposure to testicular hormones.
We find that XY and XXY mice differ in several mea-
sures of body composition and metabolic tissues includ-
ing body weight, fat mass, lean mass, and metabolic
tissue weights. Notably, these differences exist in XXY
vs. XY gonadal females as well as in gonadal males,
suggesting that these differences are caused, at least in
part, by direct genetic effects of the second X chromo-
some acting outside of the gonads rather than exclu-
sively by lower levels of testicular androgens in XXY
mice. The results represent an initial validation of the
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several phenotypes that parallel the features of KS and
because the model unveils sex chromosome effects that
would be difficult to study in humans or in previously
described mouse models.
KS men have increased rates of obesity, especially ab-
dominal obesity, and increased rates of type II diabetes
[27-33]. In this study, we show that XXY mice mimic
the KS phenotype seen in humans because they also
have increased body weight, increased body fat, and in-
creased abdominal fat pad weight, relative to XY. Also
similar to KS patients, the XXY mice differ in these mea-
sures both before and after manipulations of testoster-
one levels. Importantly, these group differences were
seen in both gonadal male and female XXY mice, impli-
cating direct genetic effects rather than hormone effects
in these traits. These results supports a growing body of
human literature that suggests that low testosterone
levels do not explain the higher rates of metabolic
disease in KS patients and that testosterone treatment is
not useful in preventing metabolic disease in these pa-
tients [28,31,33].
We hypothesized that XXY and XYY mice would have
motor deficits compared to XY mice as seen in human
patients with similar sex chromosome complement
[37,38]. We found that XXY gonadal males did not per-
form differently from XY males on two tests of motor
function but rather that the XYY males performed worse
on the pole test. The XYY vs. XY differences were not
found in gonadal females, suggesting that they represent
the effects of an overdose of Y genes that require testicu-
lar hormones. For example, the overdose of Y genes may
act on mechanisms that are masculinized by testosterone
before adulthood. These motor impairments may model
those seen in XYY humans, such as impairments in
gross motor function and coordination [37,38]. Our fail-
ure to detect motor impairments in XXY mice suggests
either that XXY mice do not effectively model the motor
deficits found in humans or that we used tests that were
not sensitive measures of the specific type of motor im-
pairment seen in KS, such as fine motor dexterity.
The differences between XXY and XY mice that we re-
port could be the result of several genetic mechanisms
that operate differently in mice with two vs. one X
chromosome [60]. About 3% of mouse X genes escape
inactivation and are expressed from both X chromo-
somes [61]. Among these are six genes (Ddx3x, Eif2s3x,
Kdm5c, Kdm6a, Uba1, and Usp9x) that are consistently
reported to be expressed higher in one or more of the
following patterns: XX > XO, XX > XY, and XXY > XY,
in numerous mouse tissues including the brain [62-67].
These six genes are X-linked in both humans and mice,
and most of them escape X inactivation in both species
[61,68-71]. We consider these genes as top candidatesfor differences between XXY and XY groups found here.
Indeed, expression profiling from the mice used in the
present study confirmed higher expression of two of
these genes in XXY vs. XY (Kdm6a and Eif2s3x) (TC
Ngun et al., unpublished work). A second category of
candidate genes are those that receive a parental im-
print, because of the presence of both parental imprints
in XXY mice, relative to the exclusively maternal imprint
in XY. This class of genes is not well described but may
include Xlr3b [72] and others [73,74]. Although XXY
karyotype in humans sometimes results from maternal
non-disjunction of X genes, in which case both X chro-
mosomes would have a maternal imprint, the SCT
model produces only XXY mice with one X chromo-
some from each parent, a condition found also in some
KS patients. A third category is more hypothetical and
includes genes that may be regulated indirectly by
heterochromatizing factors that could be modulated by
the presence of a large inactive X chromosome in cells
with two X chromosomes [75,76].
The findings that sex chromosome complement is a
significant contributing factor to body weight and body
composition is not unexpected considering that our pre-
vious work on the Four Core Genotypes mouse model
has shown that there are large sex chromosome effects
in mice such that mice with two X chromosomes are
heavier than mice with one X chromosome, regardless
of gonadal sex, in both C57BL/6J and MF1 backgrounds
[48,67]. In addition, in MF1 mice, a second sex chromo-
some of either type, X or Y, increases body weight and
adiposity, relative to mice with one sex chromosome. In
these previous reports, the sex chromosome effects were
particularly large several months after removal of the go-
nads in adulthood. In the present study, we have also
found similar sex chromosome effects both before and
after adult gonadectomy with simultaneous treatment
with testosterone. Unexpectedly, although the hormone
treatments resulted in the same levels of testosterone in
gonadal males and the same levels in gonadal females,
the levels were higher in females than males. The sex
difference in hormone levels are probably related to
body size, such that equal-sized capsules produced
higher hormone levels in the females, which were
smaller. This inference is supported by the finding that
the sex difference in testosterone levels was not signifi-
cant when body weight was used as a covariate in an
ANCOVA. Thus, the sex difference in level of testoster-
one at the end of the study could have contributed to
the male-female differences found in some of the traits.
Several previous mouse models have been used to
model KS [77-79]. One mouse model involves a four-
generation breeding scheme that produces C57BL/6
XXY and XY mice in the same litters [51-53]. This
model has been used fruitfully to discover important
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(e.g., hypogonadism, osteoporosis, and learning and
social behavioral phenotypes [58,78,80,81]), although an-
other laboratory has had difficulty with this breeding
scheme [79]. A second model, which involves breeding
commercially available C57BL/6 XY* mice, is more tract-
able [82]. This model produces XY* gonadal males and
XXY* gonadal males. The XY* chromosome is a fusion of
the non-pseudoautosomal regions of one X and one Y
chromosome end to end, connected by an aberrant
pseudoautosomal region. Thus, the XXY* gonadal male
is similar to XXY, except that it has only two sex chro-
mosomes. Comparison of XY* and XXY* indicates that
XXY* have some phenotypes typical of KS men, includ-
ing hypergonadotropic hypogonadism, infertility due to
lack of sperm, Leydig cell hyperplasia, and behavioral
deficits [59,82,83]. Therefore, the XY* model has advan-
tages because of its easier breeding scheme and validated
features similar to KS. All previous mouse models of KS
have a similar disadvantage, in that they produce XXY
and XY gonadal males only, so that differences in sex
chromosome complement are potentially confounded
with lower levels of testicular hormones found in XXY
mice [58,59]. In addition, the XXY* mouse is not com-
pletely identical genetically to XXY [48]. Although a few
studies on previous mouse models of KS have eliminated
XXY vs. XY differences in the levels of testosterone in
adulthood by castrating mice and implanting them with
testosterone pellets [43,80,81,83], the XXY and XY
groups could nevertheless be different because of long
lasting (organizational) testosterone effects on pheno-
types caused by lower androgen secretion in XXY mice
during early critical periods of development, including
prenatally. Thus, in mouse models comparing only XXY
gonadal males with XY gonadal males, it is difficult to
separate organizational hormone effects from the direct
effects of sex chromosomes on non-gonadal tissues.
In the SCT model, the gonadal sex of the animal is in-
dependent of sex chromosome complement, allowing
for improved study of the individual contributions of
direct genetic effects, hormonal effects, and interactions
of the two. The SCT model has the novel advantage of
allowing for the study of the related chromosomal ab-
normality XYY, which causes a syndrome similar to KS
but that does not involve low testosterone levels, and
which has not been well studied in animal models. The
XYY animals are also a useful control for comparing the
effects of an extra sex chromosome to the effects of an
extra X chromosome specifically. Similarly, XX males
serve as control for two X chromosomes without a third
sex chromosome. The main disadvantages of the SCT
model are the larger number of genotypes produced and
that the model is probably only viable on an outbred
background such as MF1.Some caveats are warranted. It is possible that the ex-
pression of Sry from the transgene is not identical to
that from the endogenous Sry from wild-type (WT)
mice. Phenotypically, XY−(Sry+) males are identical to
WT XY males in many but not all measured phenotypes
[46]. Because Sry is expressed outside of the testes, in
the brain, kidney, adrenals, and other tissues [84,85], it is
not possible to rule out differences between gonadal
males in the present study relative to those carrying an
endogenous Sry gene. Because the treatment of adult
mice in the current study was for 3 weeks, it is possible
that longer treatments with testosterone would have had
more dramatic effects on phenotype.
Although the association between the XXY karyotype
and KS was discovered nearly 60 years ago, the mecha-
nisms by which the extra X chromosome causes the
syndromic features of KS are still not well understood.
Currently, the treatment of KS often involves testoster-
one replacement therapy, which is understudied but
reported to have positive effects on language, intellec-
tual, and motor skills of pre-school KS boys [34,35].
Evidence suggests that in humans, not all KS phenotypes
are the result of lower androgen levels [28,31,33]. Be-
cause direct sex chromosome effects are difficult to
identify in patient populations or in previous animal
models, they are poorly understood. The SCT model
offers the opportunity to establish which phenotypic fea-
tures of XXY and XYY are independent of, or dependent
on, the gonadal effects of these trisomies. It lays the
foundation for using the power of mouse molecular gen-
etics to discover the X genes that cause KS phenotypes
and the Y genes that make XYY mice different from XY.
Conclusions
Using the novel SCT model, we have found that XXY
mice have greater body weight and increased adiposity,
relative to XY mice. These differences occur in mice that
have comparable testosterone levels as adults and are
not explained by differences in levels of testicular
secretions before adulthood. The SCT model offers
promise for further mechanistic understanding of the
differences among XXY, XYY, and XY mice that may
model differences in humans with similar genotypes.
Additional file
Additional file 1: Body composition in gonadally intact mice before
gonadectomy and after gonadectomy and treatment with
testosterone. Figure S1: body composition in gonadally intact mice
before gonadectomy. (A) Gonadal males had about 70% greater absolute
fat mass than gonadal females, irrespective of sex chromosome
complement (F(1,86) = 14.92, p = 0.0002, overall ANOVA). (B) In the
overall ANOVA, gonadal males had about 21% greater lean mass weight
than gonadal females (F(1,86) = 79.63, *p < 0.000001), irrespective of sex
chromosome complement, and the effect of sex chromosome was
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http://www.bsd-journal.com/content/4/1/15significant (F(3,86) = 2.83, *p = 0.043). In pairwise comparisons, XXY mice
had about 10% more lean mass than XY (F(1,51) = 8.88, *p = 0.004).
Values are mean ± SEM. Figure S2: body composition after
gonadectomy and treatment with testosterone. (A) Gonadal males had
about 121% greater fat mass weight than gonadal females, irrespective of
sex chromosome complement (F(1,84) = 34.42, *p < 0.000001). XXY mice
had about 60% more body fat mass than XY (F(1,51) = 7.08, *p = 0.01).
(B) Gonadal males had 17% greater lean mass than gonadal females
(F(1,84) = 63.71, *p < 0.000001) irrespective of sex chromosome
complement. XXY mice had 7% more lean mass than XY (F(1,51) = 5.14,
*p = 0.028). Values are mean ± SEM.
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